diabetes clinical research
Clinical Research Trials at Texas Diabetes

At Texas Diabetes and Endocrinology, we are dedicated to advancing medical therapies through rigorous clinical research trials. Our research department aims to test new and promising treatments before they become widely available, providing a vital service to both the medical community and our patients. 

What are clinical research trials? 

Clinical research works to advance medical or device therapies by testing new and potential treatments before they are available to the public. 

At TD&E, we offer many clinical research trials for patients to participate in if interested. 

Our research goals at TD&E are to (1) help with the advancement of new therapies and devices, and (2) to improve a patient’s quality of life by offering new and alternative therapies to which they might not otherwise have access. 

Here’s what you should know about voluntary participation in clinical research trials we offer at TD&E Research.  

What is the benefit to the patient for participating in clinical research trials? 

Clinical trials give patients an opportunity to help with the advancement of medications, devices, and innovative ways to treat different conditions and diseases. Participation in a clinical research trial also affords patients a unique opportunity to learn more about their condition and take an active role in their health. 

Are all patients eligible to participate in TD&E clinical research trials? 

Patients must first meet specific inclusion criteria to participate in a clinical trial. 

What are the additional requirements for participating in a trial? 

Clinical research trials often require additional procedures beyond what is included in your regular care such as more lab work (blood and urine samples), ECGs, questionnaires, dietician consultations, and visits with our clinical research team. Patients will be asked to keep in close contact with our office if they experience any medical or health issues associated with their new trial treatment.

How much time do research visits typically take?

Research visits can take approximately one to three hours depending on the type of visit and requirements needed for the study. 

How long do research trials usually last?

The time period for clinical trials varies, but they can last anywhere from a singular, one-time visit up to five years depending on the data needed. 

Is there a cost associated with participating in a clinical research trial at TD&E?

There is no cost to our patients for their participation, and most studies will compensate for the time and travel for completing required visits and procedures. 

Clinical Trials at Texas Diabetes and Endocrinology Research

You can learn more about our research department and currently enrolling clinical trials here. Please feel free to contact us at (512) 334-3505, option 4 to speak to a recruiter about our enrolling studies.

Don’t forget to follow us on Facebook and Instagram and check back with us each month as we provide you helpful wellness and health information.

Type 1 diabetes patient
9-year-old Georgetown boy participates in clinical trial to help find Type 1 Diabetes cure
Type 1 diabetes patient

Nine-year-old Paxton was diagnosed with Type 1 diabetes when he was just five years old. He showed the classic symptoms: extreme thirst, frequent urination, unintentional weight loss, and behavioral changes.  Both of his parents have health education backgrounds, so they immediately feared it was Type 1 diabetes. A trip to the pediatrician confirmed it. 

Type 1 diabetes is very different from Type 2 diabetes. Children who have Type 1 diabetes can’t produce the important hormone, insulin. Type 2 diabetes is typically a result of lifestyle factors, such as being inactive and carrying excess weight. 

Type 1 diabetes has a significant impact on Paxton and his family. He must check his blood sugar levels multiple times a day and must calculate how much insulin he needs. He (& his family) don’t sleep through the night because every morning at about 2am, his mom or dad checks his blood sugar levels because they typically plummet at that time. If it gets too low, Paxton could die. He is currently home-schooled because he was missing important class time due to treating blood sugar highs and lows in the nurse’s office. 

For these reasons, he’s participating in a new clinical trial at Texas Diabetes looking at special sensors and insulin pumps that make automatic adjustments to help people like Paxton stay in a more normal, healthy blood glucose range.  

“Ultra-rapid insulins being approved in pumps, including pumps with the automated features “closed loop pumps, is extremely exciting when it comes to treating patients with Type 1 diabetes”, says board certified endocrinologist, Dr. Lindsay Harrison and one of the investigators in the study.

Paxton must go to Texas Diabetes every two weeks and then eventually, it will be monthly for a total of four months. When he’s not there, he downloads his pump data and researchers access it in a cloud to watch his blood glucose levels. He must also log his food, exercise activity, and ketone levels.

This is Paxton’s third time participating in a clinical trial at Texas Diabetes. “I want to help out so other people can benefit from new technologies for Type 1,” explains Paxton. Paxton likes to explain to people exactly what Type 1 diabetes is, what the signs and symptoms are, and how it impacts his life.  He’s even recorded videos about it to share on social media.

Paxton still tries his best to live like a normal nine-year-old kid by playing with his friends and staying active through taekwondo.  

Clinical Trials at Texas Diabetes and Endocrinology

Texas Diabetes is one of the top endocrine research sites trusted worldwide in conducting investigational studies for the development of new medications and devices to help treat and prevent a wide range of endocrine diseases.

For more information on clinical research at Texas Diabetes, contact our research department here.

And don’t forget to follow us on Facebook and Instagram.

Study published in JAMA Network by Lindsay Harrison, MD

Effect of Adding Liraglutide vs Placebo to a High-Dose lnsulin Regimen in Patients With Type 2 Diabetes: A Randomized Clinical Trial

Liraglutide added to high-dose insulin therapy improved glycemic control, decreased body weight, and enhanced treatment satisfaction in this difficult-to-treat patient population with high-dose insulin requirements. Further studies are warranted to confirm these findings and evaluate the long-term risk and benefit of this treatment option.  Read more at: http://archinte.jamanetwork.com/article.aspx?articleid=2526669

First Pediatric Research Trial – Faster Acting Meal Time Insulin

READY. SET. GO!!! Texas Diabetes & Endocrinology (TDE) announced today they are scheduling for the first, of a series of several, pediatric/teen research trials. This first study will be researching an investigational faster acting meal time insulin in children ages 10 to 17 years of age who are currently on multiple daily injections of insulin. TDE states they are in continued negotiations to be involved in at least three other pediatric/teen trials this year. These include investigational insulins, sensor studies and closed loops (artificial pancreas) studies. Call now (or apply online) to find out if your child qualifies for the current insulin study and stay tuned to hear more about future studies coming… 512.334.3505 Ext. 1

Next Page »